Priscilla Biswas

Dr. Priscilla Biswas


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Blood
Verified
Journal Article
Closed access
PDF file
PBPriscilla Biswas
Priscilla Biswas
BMBarbara Mantelli
Barbara Mantelli
ASAntonio Sica
Antonio Sica
MMMauro Malnati
Mauro Malnati
CPCarla Panzeri
Carla Panzeri
ABAlberto Beretta
Alberto Beretta
CD4, the primary receptor for entry of HIV, is known to be expressed on T cells and monocytes/macrophages; healthy natural killer (NK) lymphocytes; in vitro human herpesvirus 6 (HHV6)–infected CD8+, NK, and γδ T lymphocytes; CD34+ progenitor cells; and a subset of eosinophils and basophils. We here report the unconventional expression of CD4 at the surface of peripheral blood neutrophils derived from 4 of 51 (7.8%) HIV-1–infected and 3 of 25 (12%) uninfected donors, with similar frequency within the 2 groups. The percentage of CD4+ neutrophils ranged from 39% to 97% of the total neutrophil population. Both surface and cytoplasmic forms of CD4 were present in neutrophils. Quantitative RNA polymerase chain reaction (PCR) revealed that neutrophils contain levels of CD4 mRNA comparable to those of peripheral blood mononuclear cells derived from the same donor. The conformation of CD4 expressed at the surface of neutrophils was similar to that of CD4 expressed on T lymphocytes as determined by the binding of monoclonal antibodies specific for conformational epitopes and the binding of recombinant HIV-1 gp120. Thus, our data provide evidence that neutrophils express endogenous CD4 and bind HIV. Owing to their abundance in peripheral blood, CD4+ neutrophils may influence significantly the biodistribution of HIV delivering it to sites of inflammation or to additional tissue reservoirs.

22 October 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
PBPriscilla Biswas
Priscilla Biswas
CDCinzia Carla Dellanoce
Cinzia Carla Dellanoce
AVAlessandra Vezzoli
Alessandra Vezzoli
Simona Mrakic-SpostaSimona Mrakic-Sposta
Simona Mrakic-Sposta
MMMauro Malnati
Mauro Malnati
RARoberto Accinni
Roberto Accinni
The effects of two different dietary supplements on the redox status of healthy human participants were evaluated. The first supplement (GluS, Glutathione Synthesis) contains the precursors for the endogenous synthesis of glutathione and the second (GluReS, Glutathione and Resveratrol Synthesis) contains in addition polydatin, a precursor of resveratrol. To assess the influence of GluS and GluReS on the redox status, ten thiol species and three vitamins were measured before (t0) and after 8 weeks (t1) of dietary supplementation. An inflammatory marker, neopterin, was also assessed at the same time points. Both supplements were highly effective in improving the redox status by significantly increasing the reduced-glutathione (GSH) content and other reduced thiol species while significantly decreasing the oxidized species. The positive outcome of the redox status was most significant in the GluRes treatment group which also experienced a significant reduction in neopterin levels. Of note, the endogenous levels of vitamins C, E and A were significantly increased in both treatment groups, with best results in the GluReS group. While both dietary supplements significantly contributed to recognized antioxidant and anti-inflammatory outcomes, the effects of GluReS, the combination of glutathione and resveratrol precursors, were more pronounced. Thus, dietary supplementation with GluReS may represent a valuable strategy for maintaining a competent immune status and a healthy lifespan.

1 January 2000 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PBPriscilla Biswas
Priscilla Biswas
PRPatrizia Rovere
Patrizia Rovere
CFCamilla De Filippi
Camilla De Filippi
SHSilvia Heltai
Silvia Heltai
CSCraig Smith
Craig Smith
MFMarina Ferrarini
Marina Ferrarini

7 January 2003 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
PBPriscilla Biswas
Priscilla Biswas
MFMarina Ferrarini
Marina Ferrarini
BMBarbara Mantelli
Barbara Mantelli
CFClaudio Fortis
Claudio Fortis
GPGuido Poli
Guido Poli
AMAngelo A. Manfredi
Angelo A. Manfredi
A reciprocal influence exists between mycobacteria and HIV: HIV-infected individuals are more susceptible to mycobacterial infections and, on the other hand, mycobacterial infection results inacceleration of HIV disease progression. Vγ9/Vδ2 T lymphocytes are known to participate in the defense against intracellular pathogens, including Mycobacterium tuberculosis. Indeed, they kill mycobacteria-infected macrophages and, upon recognition of mycobacterial Ag, release TNF-α and IFN-γ, which are also up-regulators of HIV expression. To assess whether mycobacteria-activated γ δ T lymphocytes contribute to the enhancement of HIV replication, we established an in vitro model mimicking HIV and mycobacteria co-infection with the latently HIV-infected promonocytic U1 cell line and Vγ9/Vδ2 peripheral lymphocytes stimulated with mycobacterial Ag. γ δ T cell activation determined two distinct, but connected effects, namely U1cell death and HIV expression. Both effects were mainly mediated by release of TNF-α and IFN-γ from activated γ δ lymphocytes, although Fas-FasL interaction also contributed to U1 apoptosis. The final outcome on U1 survival, and thus, on HIV expression, highly depended on mycobacterial Ag concentration coupled to the differential secretory potency of γ δ cells. In particular, the induction of viral expression prevailed at low Ag concentration and with lower cytokine production by mycobacteria-activated γ δ cells. Notably, during the course of HIV infection, Vγ9/Vδ2 lymphocytes are reported to be functionally impaired and may thus indirectly influence the progression of HIV disease. In addition, a predominant inhibition of viral replication was encountered when mycobacteria-activated γ δ T cells were co-cultured with primary HIV-infected macrophages. Thus, we suggest that specific recognition of mycobacterial Ag by γ δ T lymphocytes in co-infected individuals may modulate viral replication through the complex array of soluble factors released.

1 January 2001 in Cytokine
Verified
Journal Article
Closed access
PBPriscilla Biswas
Priscilla Biswas
BMBarbara Mantellib
Barbara Mantellib
FDFanny Delfantia
Fanny Delfantia
MCManuela Cotab
Manuela Cotab
GVGiuliana Vallantib
Giuliana Vallantib
GPGuido Poli
Guido Poli

19 July 2013 in Vaccines
Verified
Journal Article
Open access
PDF file
MBMarie Borggren
Marie Borggren
LVLasse Vinner
Lasse Vinner
BABetina Skovgaard Andresen
Betina Skovgaard Andresen
BGBerit Grevstad
Berit Grevstad
JRJohanna Repits
Johanna Repits
AFAnders Fomsgaard
Anders Fomsgaard
HIV-1 DNA vaccines have many advantageous features. Evaluation of HIV-1 vaccine candidates often starts in small animal models before macaque and human trials. Here, we selected and optimized DNA vaccine candidates through systematic testing in rabbits for the induction of broadly neutralizing antibodies (bNAb). We compared three different animal models: guinea pigs, rabbits and cynomolgus macaques. Envelope genes from the prototype isolate HIV-1 Bx08 and two elite neutralizers were included. Codon-optimized genes, encoded secreted gp140 or membrane bound gp150, were modified for expression of stabilized soluble trimer gene products, and delivered individually or mixed. Specific IgG after repeated i.d. inoculations with electroporation confirmed in vivo expression and immunogenicity. Evaluations of rabbits and guinea pigs displayed similar results. The superior DNA construct in rabbits was a trivalent mix of non-modified codon-optimized gp140 envelope genes. Despite NAb responses with some potency and breadth in guinea pigs and rabbits, the DNA vaccinated macaques displayed less bNAb activity. It was concluded that a trivalent mix of non-modified gp140 genes from rationally selected clinical isolates was, in this study, the best option to induce high and broad NAb in the rabbit model, but this optimization does not directly translate into similar responses in cynomolgus macaques.